Biotech SF
San Francisco Bay Area biotech stories.
Wednesday, August 22, 2012
Xoma files $100 million mixed shelf offering
Xoma Corp. filed a shelf offering Wednesday that would let it sell $100 million worth of common stock, preferred stock, debt securities and warrants
.
Xoma plans to use the money for working capital and general corporate purposes, including research and development expenses and capital expenditures, it said in a Securities and Exchange Commission filing.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment